Skip to content
Inciteful Med

Syndromic Albinism: When It Is More Than Skin and Eyes

Last updated:

Syndromic albinism is a rare group of genetic conditions where albinism is accompanied by serious systemic issues, such as bleeding disorders in Hermansky-Pudlak Syndrome or immune deficiencies in Chediak-Higashi Syndrome. Diagnosis requires specialized blood and genetic testing.

Key Takeaways

  • • Syndromic albinism involves genetic mutations that affect not just pigmentation, but vital systems like the lungs, immune system, and brain.
  • • Hermansky-Pudlak Syndrome (HPS) combines albinism with a bleeding disorder and a high risk for serious lung scarring (pulmonary fibrosis) later in life.
  • • Chediak-Higashi and Griscelli Syndromes feature severe immune deficiencies that make fighting infections extremely difficult and may require a bone marrow transplant.
  • • Vici Syndrome is a progressive multisystem disorder characterized by albinism, abnormal brain development, cataracts, and heart muscle weakness.
  • • Doctors diagnose these rare syndromes using specialized tests like platelet electron microscopy, peripheral blood smears, and whole exome genetic sequencing.

While most cases of albinism only affect the eyes, skin, and hair, in some rare instances, albinism is a sign of a more serious, systemic condition called a “syndrome” [1][2]. In these cases, the genetic mutation doesn’t just block melanin production; it disrupts how cells transport vital materials to other organs, such as the lungs, the immune system, and the brain [1][3].

It is critical to distinguish between non-syndromic OCA and these syndromes because the syndromes require specialized, life-saving medical care. However, it is important not to panic: most of these rare syndromes present with severe, obvious symptoms in infancy or early childhood, not suddenly in adulthood.

Hermansky-Pudlak Syndrome (HPS)

HPS is characterized by albinism combined with a bleeding diathesis (a tendency to bleed easily) [4][5]. This happens because the platelets—the cells that help blood clot—lack “dense granules” that store necessary chemicals [6][7].

  • Key Warning Signs: Easy bruising, frequent nosebleeds, and heavy or prolonged bleeding after minor cuts or dental work [8][9]. The bleeding tendency is lifelong.
  • Serious Risks: The most dangerous complication is pulmonary fibrosis (scarring of the lungs), which is highly likely in subtypes HPS-1 and HPS-4 [10][11]. This typically begins later in life, usually in a person’s 30s or 40s, and can lead to respiratory failure [12][13]. Some patients also develop granulomatous colitis, which is similar to Crohn’s disease [14].

Chediak-Higashi Syndrome (CHS)

CHS is an extremely rare and life-threatening condition where the body’s white blood cells cannot fight infections properly [15][16]. It is typically diagnosed in early childhood.

  • Key Warning Signs: Recurrent, severe bacterial infections and “silvery” or metallic-tinted hair [15][17].
  • Serious Risks: Most patients enter an “accelerated phase” called Hemophagocytic Lymphohistiocytosis (HLH), a massive, life-threatening overreaction of the immune system that requires urgent treatment, often a bone marrow transplant [18][2]. Progressive neurological issues, like clumsiness or tremors, may also develop [19].

Griscelli Syndrome (GS Type 2)

Like CHS, Griscelli Syndrome Type 2 involves albinism and a severe immune deficiency [20][17]. It is also usually identified in infancy or early childhood.

  • Key Warning Signs: Frequent infections and a large, irregular clumping of pigment in the hair shafts visible under a microscope [20][21].
  • Serious Risks: Like CHS, patients with Type 2 are at extremely high risk for the life-threatening HLH immune reaction [20][17].

Vici Syndrome

Vici Syndrome is a rare, severe multisystem disorder that includes albinism as one of its five “core” features [22][23]. Symptoms are obvious shortly after birth.

  • The Five Principal Signs:
    1. Albinism (hypopigmentation) [22].
    2. Agenesis of the corpus callosum (missing the bridge between the two halves of the brain) [22].
    3. Cataracts (clouding of the eye lens) [22].
    4. Cardiomyopathy (weakening of the heart muscle) [22].
    5. Combined immunodeficiency [22].
  • Serious Risks: This is a progressive disorder with severe developmental delays and a shortened lifespan, often due to heart failure or severe infections [24][25].

How Doctors Test for Syndromes

If a doctor suspects a syndromic form of albinism based on bleeding history or frequent infections, they will use specialized tests:

  • Platelet Electron Microscopy (EM): This is the “gold standard” for HPS; it uses a powerful microscope to see if the required dense granules are missing from the platelets [6][7].
  • Peripheral Blood Smear: A simple blood test where a technician looks for “giant granules” inside white blood cells, which is the hallmark of Chediak-Higashi Syndrome [16][26].
  • Genetic Testing (WES/NGS): Whole Exome Sequencing or Next-Generation Sequencing can definitively identify the specific gene mutation (such as HPS1, LYST, RAB27A, or EPG5) to confirm which syndrome is present [27][28][29].
  • Flow Cytometry: A fast way to look at how cells are behaving, sometimes used to check platelet function or immune cell activity [30].

Frequently Asked Questions

What is syndromic albinism?
Syndromic albinism occurs when the genetic mutation causing albinism also disrupts other parts of the body, such as the immune system, lungs, or blood clotting. These are rare conditions that require specialized medical care beyond standard vision and skin protection.
Why do some people with albinism bruise or bleed easily?
Easy bruising, frequent nosebleeds, or heavy bleeding can be a sign of Hermansky-Pudlak Syndrome (HPS). In HPS, the blood platelets lack the necessary storage granules to form clots properly, leading to a lifelong bleeding tendency.
Are the symptoms of syndromic albinism obvious?
Most rare albinism syndromes present with severe, obvious symptoms in infancy or early childhood. These often include frequent severe infections, heavy bleeding from minor cuts, or significant developmental delays, rather than appearing suddenly in adulthood.
How do doctors test for syndromic albinism?
Doctors use specialized lab and genetic tests to diagnose syndromic albinism. This may include a peripheral blood smear, platelet electron microscopy to check blood clotting cells, or whole exome sequencing to identify the exact genetic mutation.
What is Chediak-Higashi Syndrome?
Chediak-Higashi Syndrome is an extremely rare, life-threatening form of syndromic albinism where white blood cells cannot fight infections properly. It is usually diagnosed in early childhood and often presents with silvery hair and severe, recurrent bacterial infections.

Questions for Your Doctor

  • • Does my child (or do I) have any signs of platelet storage pool deficiency that would require further testing like electron microscopy?
  • • Is a baseline high-resolution CT (HRCT) scan or pulmonary function test necessary to monitor for early signs of lung disease?
  • • Should we perform a peripheral blood smear specifically to look for the 'giant granules' that identify Chediak-Higashi Syndrome?
  • • If a syndromic form is suspected, is Whole Exome Sequencing the most effective way to identify the specific gene mutation?
  • • What is our emergency plan if my child develops a high fever or signs of a severe, recurrent infection?

Questions for You

  • • Have I noticed any unusual bruising, frequent nosebleeds, or bleeding that takes a long time to stop after a minor cut or scrape?
  • • Has my child had frequent or severe infections, like pneumonia or skin abscesses, that seemed harder to treat than expected?
  • • Are there any developmental milestones, such as crawling, walking, or speaking, that I am concerned about or that seem to be regressing?
  • • Have I noticed any heart-related symptoms like unusual fatigue or difficulty breathing during physical activity?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Albinism: from genetics to cell biology and physiopathology.

    Diallo M, Salavessa L, Arveiler B, Delevoye C

    Presse medicale (Paris, France : 1983) 2025; (55(3)):104333 doi:10.1016/j.lpm.2025.104333.

    PMID: 41314540
  2. 2

    Primary immunodeficiency associated with hypopigmentation: A differential diagnosis approach.

    Zamani R, Shahkarami S, Rezaei N

    Allergologia et immunopathologia 2021; (49(2)):178-190 doi:10.15586/aei.v49i2.61.

    PMID: 33641308
  3. 3

    Melanosome transport and regulation in development and disease.

    Tian X, Cui Z, Liu S, et al.

    Pharmacology & therapeutics 2021; (219()):107707 doi:10.1016/j.pharmthera.2020.107707.

    PMID: 33075361
  4. 4

    A Rare Case of Hermansky-Pudlak Syndrome Type 3.

    Alcid J, Kim J, Bruni D, Lawrence I

    Journal of hematology 2018; (7(2)):76-78 doi:10.14740/jh387w.

    PMID: 32300417
  5. 5

    Lung Transplantation for Pulmonary Fibrosis Associated With Hermansky-Pudlak Syndrome. A Single-center Experience.

    Benvenuto L, Qayum S, Kim H, et al.

    Transplantation direct 2022; (8(4)):e1303 doi:10.1097/TXD.0000000000001303.

    PMID: 35350109
  6. 6

    A novel two-nucleotide deletion in HPS6 affects mepacrine uptake and platelet dense granule secretion in a family with Hermansky-Pudlak syndrome.

    Andres O, Wiegering V, König EM, et al.

    Pediatric blood & cancer 2017; (64(5)) doi:10.1002/pbc.26320.

    PMID: 27917594
  7. 7

    Severe bleeding with subclinical oculocutaneous albinism in a patient with a novel HPS6 missense variant.

    Han CG, O'Brien KJ, Coon LM, et al.

    American journal of medical genetics. Part A 2018; (176(12)):2819-2823 doi:10.1002/ajmg.a.40514.

    PMID: 30369044
  8. 8

    A rare cause of thrombocyte dysfunction: Hermansky-Pudlak syndrome.

    Özdemir N, Çelik E, Başlar Z, Celkan T

    Turk pediatri arsivi 2014; (49(2)):163-6 doi:10.5152/tpa.2014.1071.

    PMID: 26078655
  9. 9

    Coexistence of Hermansky-Pudlak syndrome and JAK2V617F-positive essential thrombocythemia.

    Eskazan T, Erturkuner SP, Isildar B, et al.

    Ultrastructural pathology 2019; (43(1)):94-98 doi:10.1080/01913123.2019.1593269.

    PMID: 30932722
  10. 10

    Hermansky-Pudlak Syndrome.

    Wang JY, Young LR

    Clinics in chest medicine 2025; (46(4)):701-710 doi:10.1016/j.ccm.2025.07.009.

    PMID: 41110930
  11. 11

    Hermansky-Pudlak syndrome with interstitial lung disease: A holistically worked up couplet.

    Gupta A, Utpat K, Desai U, Joshi JM

    Lung India : official organ of Indian Chest Society 2019; (36(4)):345-348 doi:10.4103/lungindia.lungindia_258_18.

    PMID: 31290422
  12. 12

    Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease.

    Yokoyama T, Gochuico BR

    European respiratory review : an official journal of the European Respiratory Society 2021; (30(159)) doi:10.1183/16000617.0193-2020.

    PMID: 33536261
  13. 13

    Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.

    Vicary GW, Vergne Y, Santiago-Cornier A, et al.

    Annals of the American Thoracic Society 2016; (13(10)):1839-1846 doi:10.1513/AnnalsATS.201603-186FR.

    PMID: 27529121
  14. 14

    Refractory Colitis in Hermansky-Pudlak Syndrome: A Surgical Case Report.

    Serpa-Irizarry M, Rodriguez-Reyes D, Mejias-Febres ED, et al.

    Cureus 2025; (17(6)):e86548 doi:10.7759/cureus.86548.

    PMID: 40698202
  15. 15

    Generation and characterization of four Chediak-Higashi Syndrome (CHS) induced pluripotent stem cell (iPSC) lines.

    Serra-Vinardell J, Sandler MB, Pak E, et al.

    Stem cell research 2020; (47()):101883 doi:10.1016/j.scr.2020.101883.

    PMID: 32619719
  16. 16

    Role of Morphology in the Diagnosis of an Unsuspected Case of Chediak-Higashi Syndrome: A Case Report.

    Rajyalakshmi R, Kusa Raju P

    Cureus 2024; (16(12)):e75128 doi:10.7759/cureus.75128.

    PMID: 39759654
  17. 17

    Case series on Silvery Hair Syndromes: Single Center Experience.

    Siddiahgari S, Soma SK, Penmetcha C, et al.

    Indian journal of dermatology 2022; (67(2)):164-168 doi:10.4103/ijd.IJD_723_20.

    PMID: 36092238
  18. 18

    Masquerading as lymphoma: the accelerated phase of Chediak-Higashi syndrome and its novel mutation.

    Aggarwal P, Agarwal A, Aggarwal S, et al.

    Journal of applied genetics 2025; (66(3)):653-656 doi:10.1007/s13353-025-00986-0.

    PMID: 40591236
  19. 19

    Chediak-Higashi syndrome.

    Talbert ML, Malicdan MCV, Introne WJ

    Current opinion in hematology 2023; (30(4)):144-151 doi:10.1097/MOH.0000000000000766.

    PMID: 37254856
  20. 20

    Griscelli Syndrome: A Case Report from Pakistan, A Review of the Literature, and an Approach to Hematological Disorders Associated With Albinism.

    Afzal M, Ashraf S, Humayun L, et al.

    Cureus 2025; (17(6)):e86445 doi:10.7759/cureus.86445.

    PMID: 40688996
  21. 21

    Early diagnosis of immunodeficient patients with partial albinism: The role of hair study and peripheral blood smear.

    Tajik S, Fazlollahi MR, Alizadeh Z, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2024; (35(11)):e14264 doi:10.1111/pai.14264.

    PMID: 39485047
  22. 22

    Phenotypic expansion of EGP5-related Vici syndrome: 15 Dutch patients carrying a founder variant.

    Vansenne F, Fock JM, Stolte-Dijkstra I, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2022; (41()):91-98 doi:10.1016/j.ejpn.2022.11.003.

    PMID: 36410285
  23. 23

    Vici syndrome: a review.

    Byrne S, Dionisi-Vici C, Smith L, et al.

    Orphanet journal of rare diseases 2016; (11()):21 doi:10.1186/s13023-016-0399-x.

    PMID: 26927810
  24. 24

    Novel EPG5 Mutation Associated with Vici Syndrome Gene.

    Mahjoubi F, Shabani S, Khakbazpour S, Khaligh Akhlaghi A

    Case reports in genetics 2022; (2022()):5452944 doi:10.1155/2022/5452944.

    PMID: 35846893
  25. 25

    A Saudi Infant with Vici Syndrome: Case Report and Literature Review.

    Alzahrani A, Alghamdi AA, Waggass R

    Open access Macedonian journal of medical sciences 2018; (6(6)):1081-1084 doi:10.3889/oamjms.2018.271.

    PMID: 29983806
  26. 26

    Chediak-Higashi syndrome presenting in accelerated phase: A case report and literature review.

    Maaloul I, Talmoudi J, Chabchoub I, et al.

    Hematology/oncology and stem cell therapy 2016; (9(2)):71-5.

    PMID: 26254864
  27. 27

    A novel 5bp deletion in HPS4 gene associates with Hermansky-Pudlak Syndrome.

    Premkumar S, Shiva Sankari S, Sandhra G, et al.

    Ophthalmic genetics 2025; (46(5)):474-478 doi:10.1080/13816810.2025.2502361.

    PMID: 40383711
  28. 28

    A Novel Likely Pathogenic Variant in the BLOC1S5 Gene Associated with Hermansky-Pudlak Syndrome Type 11 and an Overview of Human BLOC-1 Deficiencies.

    Boeckelmann D, Wolter M, Käsmann-Kellner B, et al.

    Cells 2021; (10(10)) doi:10.3390/cells10102630.

    PMID: 34685610
  29. 29

    Chédiak-Higashi syndrome presenting as a hereditary spastic paraplegia.

    Koh K, Tsuchiya M, Ishiura H, et al.

    Journal of human genetics 2022; (67(2)):119-121 doi:10.1038/s10038-021-00977-z.

    PMID: 34483340
  30. 30

    Rapid Diagnosis and Subtyping of Hermansky-Pudlak Syndrome With Flow Cytometry Analysis.

    Zhang Y, Liu T, Yang Q, et al.

    Pigment cell & melanoma research 2025; (38(5)):e70048 doi:10.1111/pcmr.70048.

    PMID: 40913269

This page provides educational information about syndromic albinism types, including HPS and CHS. It is not a substitute for professional medical advice, diagnosis, or genetic counseling. Always consult your healthcare provider about specific symptoms or testing.

Stay up to date

Get notified when new research about Oculocutaneous albinism is published.

No spam. Unsubscribe anytime.